|
APPLERA CORP-CELE, (CRA) Stock Research Free Stock Rating
|
|
| |
| Company Profile |
| |
|
Applera Corporation-Celera Genomics Group engages in the discovery and development of targeted therapeutics for cancer, autoimmune, and inflammatory diseases. The company supports its proteomic, bioinformatic, and genomic capabilities to identify and validate drug targets, and to discover and develop small molecule therapeutics. It also seeks to advance therapeutic antibody and selected small molecule drug programs in collaboration with various companies. Celera Genomics has strategic collaborations with Abbott Laboratories; General Electric; Merck & Co., Inc.; and Seattle Genetics, Inc. It also has collaborations with Aventis Pharma, Genentech, Inc., and MAXIM PHARMACUETICALS. The company was founded by Applera Corporation and J. Craig Venter in 1998. The company is headquartered in Norwalk, Connecticut. Applera Corporation-Celera Genomics Group is a division of Applera Corporation, as of July 28, 2004.
|
APPLERA CORP-CELE Related |
|
Celera Stock Price (CRA), Stock Quotes, Charts, Trades, Market News Celera stock Price (CRA), Stock Quotes and FREE real time streaming Celera Stock ... Oct 28 (Reuters) - Celera Corp: * Reports third quarter calendar 2008 ...
|
|
Barchart.com - Sectors - Bottom 100 Stocks APPLERA CORP-AP -18.30. 30.22. 47.20% 71.61% 2243843 -10.79% 37.63. 25.85. PSDV. PSIVIDA LIMITED ... APPLERA CP-CELE -26.00. 11.04. 45.55% 83.42% 642400 -30.43 ...
|
|
Www.igmarkets.com ... AAPL.O,Yes,0.30%,10% Applera Corp - Applied Biosystems,USA,ABI.N,Yes, ... 10% Celanese Corp,USA,CE.N,Yes,0.30%,25% Celera Genomics Group - Applera,USA,CRA, ...
|
|
